Trial of Artesunate Combination Therapy in Pakistan
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This study is an evaluation of the benefit of adding artesunate to existing first and second
line antimalarial therapies in Pakistan.
A placebo controlled trial was carried out to assess two potential benefits of Artesunate
Combination Therapy (ACT): efficacy and potential for transmission reduction.